Ms. Rosen Schwarz leads strategy, operations and vision for C8 Health’s AI-powered clinical knowledge platform, now deployed across more than 100 U.S. hospitals including 30 top academic medical centers such as New York City-based Mount Sinai, San Francisco-based UCSF Health and Boston-based Brigham & Women’s. The platform follows a repeatable 31.5-day deployment model that achieves 90-plus % sustained clinician adoption after 12 months. At Galveston, Texas-based UTMB Health, C8 Health drove a 9.1% absolute increase in perioperative glucose compliance within three months, with 39% of previously non-compliant providers becoming compliant, projecting $1.5 million in annual savings. At Cleveland-based MetroHealth, 100% clinician adoption was paired with a fivefold improvement in timely protocol access, improving from 15% to 79%, and a quadrupling of satisfaction with knowledge delivery, rising from 22% to 86%. In 2025, Ms. Rosen Schwarz closed a $12 million Series A from Team8, 10D and Vertex Ventures Israel and finalized a partnership with the American Society of Anesthesiologists that launched “Evidence Compare,” an automated tool aligning hospital protocols with national guidelines. She has built one of healthtech’s most gender-balanced organizations, with women comprising 50% of C8’s management team and 40% of its overall workforce. She was named No. 36 in Techround‘s “50WomenInTech” and received a Stevie’s bronze “Woman of the Year” in healthcare recognition.
